Skip to main content
Fig. 1 | BMC Surgery

Fig. 1

From: Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis

Fig. 1

Overall, disease-free, and hematogenous metastasis-free survival in patients following curative pancreatic surgery with (red line) and without aspirin (blue line). Depicted is a overall survival, b disease-free survival, and c hematogenous metastasis free survival (HFMS) in months following pancreatic surgery. p-values were calculated by log-rank test

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us